Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-05-19
1993-11-16
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514450, 536 71, 549264, A61K 3170, A61K 31365
Patent
active
052624005
ABSTRACT:
Avermectin compounds are substituted at the 4a-position: the 4a-methyl group is first derivatized with a hydroxy group which is then substituted with a variety of alkyl, alkoxy alkyl, or polyalkoxy alkyl groups and derivatives thereof. The compounds are potent antiparasitic and anthelmintic agents and compositions for such uses are also disclosed.
REFERENCES:
patent: 3950360 (1976-04-01), Aoki et al.
patent: 4171314 (1979-10-01), Chabala et al.
patent: 4206205 (1980-06-01), Mrozik et al.
patent: 4310519 (1982-01-01), Albers-Schonberg et al.
patent: 4457920 (1984-07-01), Mrozik et al.
Albers-Schonberg, et al (II) J. Am. Soc. 103 pp. 4216-4221 (1981).
Chabala, et al (III) J. Med. Chem. 23 pp. 1134-1136 (1980).
Carter, et al J. Antibiotics 41 pp. 519-529 (1988).
Danishefsky, et al J. Am. Chem. Soc. 111 (1989) pp. 2967-2980.
Hanessien, et al. (I) J. Am. Chem. Soc. 109 (1987) pp. 7063-7067.
Fraser-Reid, et al J. Am. Chem. Soc. 109 (1987) pp. 933-935.
Derwent Abstract, 90-063696/09.
Chu Lin
Jones Todd K.
Mrozik Helmut
DiPrima Joseph F.
Ivy C. Warren
Merck & Co. , Inc.
Owens A.
Rose David L.
LandOfFree
4.alpha.-substituted avermectin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4.alpha.-substituted avermectin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4.alpha.-substituted avermectin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22617